These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 15265968

  • 1. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1070-6. PubMed ID: 15265968
    [Abstract] [Full Text] [Related]

  • 2. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I, Potard V, Costagliola D.
    Antivir Ther; 2006 Jul 21; 11(8):1091-6. PubMed ID: 17302379
    [Abstract] [Full Text] [Related]

  • 3. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):577-86. PubMed ID: 15840880
    [Abstract] [Full Text] [Related]

  • 4. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):100-9. PubMed ID: 16418512
    [Abstract] [Full Text] [Related]

  • 5. Effect of HIV infection on atypical squamous cells of undetermined significance.
    Duerr A, Paramsothy P, Jamieson DJ, Heilig CM, Klein RS, Cu-Uvin S, Schuman P, Anderson JR, HIV Epidemiology Research Study.
    Clin Infect Dis; 2006 Mar 15; 42(6):855-61. PubMed ID: 16477565
    [Abstract] [Full Text] [Related]

  • 6. Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004.
    Drogoul-Vey MP, Marimoutou C, Robaglia-Schlupp A, Beerli M, Gastaut JA, Cau P, Poizot-Martin I.
    AIDS Care; 2007 Sep 15; 19(8):1052-7. PubMed ID: 17852004
    [Abstract] [Full Text] [Related]

  • 7. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):425-32. PubMed ID: 15770006
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, Anderson J, Shah KV, HIV Epidemiology Research Study (HERS) Group.
    J Infect Dis; 2003 Jul 01; 188(1):128-36. PubMed ID: 12825181
    [Abstract] [Full Text] [Related]

  • 9. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K, DIANAIDS Collaborative Study Group.
    Int J STD AIDS; 2003 Jun 01; 14(6):417-25. PubMed ID: 12816671
    [Abstract] [Full Text] [Related]

  • 10. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat NB.
    J Infect Dis; 2003 Aug 15; 188(4):555-63. PubMed ID: 12898443
    [Abstract] [Full Text] [Related]

  • 11. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
    Chu H, Gange SJ, Yamashita TE, Hoover DR, Chmiel JS, Margolick JB, Jacobson LP.
    Am J Epidemiol; 2005 Oct 15; 162(8):787-97. PubMed ID: 16135508
    [Abstract] [Full Text] [Related]

  • 12. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women.
    Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM.
    Cancer Epidemiol Biomarkers Prev; 2003 Jul 15; 12(7):638-42. PubMed ID: 12869403
    [Abstract] [Full Text] [Related]

  • 13. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ.
    Clin Infect Dis; 2008 Jan 15; 46(2):305-12. PubMed ID: 18171267
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C.
    J Infect Dis; 2001 Sep 01; 184(5):547-51. PubMed ID: 11494160
    [Abstract] [Full Text] [Related]

  • 15. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.
    Palefsky JM.
    Semin Oncol; 2000 Aug 01; 27(4):471-9. PubMed ID: 10950374
    [Abstract] [Full Text] [Related]

  • 16. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G, Italian MASTER Cohort.
    Antivir Ther; 2007 Aug 01; 12(6):941-7. PubMed ID: 17926648
    [Abstract] [Full Text] [Related]

  • 17. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 18. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD, Keruly JC.
    Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
    Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD, Palefsky JM.
    Sex Transm Dis; 2004 Feb 01; 31(2):96-9. PubMed ID: 14743072
    [Abstract] [Full Text] [Related]

  • 20. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C.
    Clin Infect Dis; 2005 Feb 01; 40(3):451-7. PubMed ID: 15668870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.